Drugmakers Push Back Against Canada’s New Pricing…
Pushback from drug companies on Canada’s newest drug pricing regulations has led the country’s regulatory body to reconsider their…
Tagged with PMPRB
Interview: Douglas Clark – Executive Director, Patented…
Douglas Clark, Executive Director of the Patented Medicine Prices Review Board (PMPRB), Canada’s federal price regulator for patented medicines,…
